@HalevyMike Avatar @HalevyMike Mike.Halevy

Mike.Halevy posts on X about $xbi, $nvo, $lly, $beam the most. They currently have [-----] followers and [---] posts still getting attention that total [------] engagements in the last [--] hours.

Engagements: [------] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 60% cryptocurrencies 38% currencies 18% countries 9% technology brands 8% celebrities 6% finance 5% automotive brands 2%

Social topic influence $xbi #15, $nvo #57, $lly #36, $beam #31, $pfe #79, $crsp #5, $ntla 24%, $prme #7, $mrk 21%, $rhhby 20%

Top accounts mentioned or mentioned by @yaireinhorn @elonmusk @crisprtx @beamtx @intelliatx @evaluatepharma @cariboubio @spacex @realdonaldtrump @billackman @ft @davidrliu @maximusholla @brandonvanzee @timopler @wavelifesci @pfizer @cariboubios @unusualwhales @johnevans3

Top assets mentioned Novo-Nordisk (NVO) Eli Lilly and Company (LLY) BEAM (BEAM) Pfizer, Inc. (PFE) CRISPR Therapeutics AG (CRSP) Intellia Therapeutics, Inc (NTLA) Prime Medicine, Inc. (PRME) Merck & Co., Inc. (MRK) Bristol-Myers Squibb Co (BMY) AstraZeneca PLC (AZN) AbbVie Inc (ABBV) Johnson & Johnson (JNJ) Caribou Biosciences, Inc. (CRBU) Novartis AG (NVS) Abivax SA (ABVX) Sana Biotechnology, Inc. (SANA) Synthetify (SNY) Verve Therapeutics Inc. (VERV) Gilead Sciences, Inc. (GILD) Revolution Medicines, Inc. (RVMD) Amgen, Inc. (AMGN) Regeneron Pharmaceuticals Inc (REGN) GSK plc (GSK) NVIDIA Corp. (NVDA) Hims & Hers Health, Inc. (HIMS) Wave Life Sciences Ltd. Ordinary Shares (WVE) Metagenomi Technologies, LLC (MGX) Apple, Inc. (AAPL) Recursion Pharmaceuticals, Inc. (RXRX) Tesla, Inc. (TSLA) Arrowhead Research Corporation (ARWR) Viking Therapeutics, Inc (VKTX) Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Axsome Therapeutics, Inc (AXSM) Bluefin (BLUE) Microsoft Corp. (MSFT) Alphabet Inc Class A (GOOGL) Alnylam Pharmaceuticals, Inc. (ALNY) Summit Therapeutics Inc. Common Stock (SMMT) Metsera, Inc. (MTSR) uniQure N.V. (QURE)

Top Social Posts

Top posts by engagements in the last [--] hours

"here is another one of @yaireinhorn excellent articles which are very informative and helpful especially for some like me who lacks the basic knowledge and understanding in biotech but who wants to learn. thank you $crsp $beam $ntla $xbi $abvx $rvmd $prme $lly $nvo $crbu $sana $teva https://t.co/bzmcG6dEtw https://t.co/bzmcG6dEtw"
X Link 2026-01-29T13:35Z [----] followers, [----] engagements

"RT @elonmusk: Grok downloads surge 43% month over month"
X Link 2026-02-09T15:57Z [----] followers, [----] engagements

"RT @elonmusk: Civilization on the Moon"
X Link 2026-02-09T15:57Z [----] followers, 11.4K engagements

"#crispr #biotech $crbu $prme $beam $crsp $sana $pfe $Nvo $hims $lly #geneediting 1/🚨WOW $CRBU has presented updated clinical data from @CaribouBio ongoing CB-011 CaMMouflage phase [--] clinical trial in cancer patients with relapsed or refractory multiple myeloma (r/r MM). The CB-011 CaMMouflage phase [--] translational and clinical data - which was presented at https://t.co/emfrwEHgux 1/🚨WOW $CRBU has presented updated clinical data from @CaribouBio ongoing CB-011 CaMMouflage phase [--] clinical trial in cancer patients with relapsed or refractory multiple myeloma (r/r MM). The CB-011 CaMMouflage"
X Link 2026-02-09T15:59Z [----] followers, [---] engagements

"RT @yaireinhorn: 🚨🚨WOW Not only did $NVO has finally announced that it has filed a lawsuit against $HIMS but Novo Nordisk is suing for in"
X Link 2026-02-09T15:59Z [----] followers, [--] engagements

"$xbi $crbu $pfe #crispr #geneediting #biotech #cancer In my opinion its worth emphasising the deep involvement of @pfizer in @CaribouBios CB-011 🧵👇- which is currently one of Pfizers biggest investment in the CRISPR and Gene Editing space. In July [----] $CRBU announced that $PFE has made a $25M equity investment aimed to https://t.co/xz83HZFFX2 In my opinion its worth emphasising the deep involvement of @pfizer in @CaribouBios CB-011 🧵👇- which is currently one of Pfizers biggest investment in the CRISPR and Gene Editing space. In July [----] $CRBU announced that $PFE has made a $25M equity"
X Link 2026-02-11T18:51Z [----] followers, [---] engagements

"RT @unusual_whales: Good morning to everyone:"
X Link 2026-02-16T15:52Z [----] followers, [--] engagements

"RT @elonmusk: Yes"
X Link 2026-02-16T15:53Z [----] followers, 13.7K engagements

"RT @yaireinhorn: 1/🚨 This short and excellent FT article tells the tale of AstraZenecas huge success story and how $AZN is paving its way"
X Link 2026-02-16T15:54Z [----] followers, [--] engagements

"$beam $prme $abvx $ntvx $lly $nvo $crsp $xbi #crispr #biotech $sgmo #geneediting @john_evans3 @BeamTx Congrats to @john_evans3 - @beamtx CEO on being a part of the TIME100s Health list which includes the [---] most influential people in the health industry today. In March [----] $BEAM presented promising data 🧵👇 from its Phase 1/2 trial of BEAM-302 in Alpha-1 Antitrypsin https://t.co/rVDiDBEMxj Congrats to @john_evans3 - @beamtx CEO on being a part of the TIME100s Health list which includes the [---] most influential people in the health industry today. In March [----] $BEAM presented promising"
X Link 2026-02-15T18:57Z [----] followers, [----] engagements

"$azn $pfe $jnj $nvs $bmy $gsk $abbv $mrk $sny #biotech #pharma #cancer $nvo $lly $xbi $amgn $rhhby $aapl $tsla $abvx $rvmd $sgmo 1/🚨 This short and excellent FT article tells the tale of AstraZenecas huge success story and how $AZN is paving its way towards fulfilling its ambitious corporate goal of $80B in revenue by [----]. This massive achievement is based mainly on a fantastic track record of [--] https://t.co/WfYnmDHjTV 1/🚨 This short and excellent FT article tells the tale of AstraZenecas huge success story and how $AZN is paving its way towards fulfilling its ambitious corporate goal of"
X Link 2026-02-16T15:56Z [----] followers, [---] engagements

"@yaireinhorn @neuralink @SpaceX @elonmusk @kraneland @NeuraPodLatino @matty_mogul @SERobinsonJr @BigCrete @RominaNejad @jjhanna2 @habenet @hovmoses amazing. god bless @elonmusk"
X Link 2024-10-15T18:24Z [---] followers, [---] engagements

"@realDonaldTrump stand with Israel against Iran mister president"
X Link 2024-10-15T18:27Z [---] followers, [--] engagements

"@yaireinhorn @SpencerLndqst @IvankaTrump @IvankaNews_ @DonaldJTrumpJr @MELANIATRUMP @GOP @HouseGOP @benshapiro @BillAckman @GadSaad @mayemusk Im also voting this time for president Trump. Stay safe Yair"
X Link 2024-10-30T04:37Z [----] followers, [---] engagements

"@JDVance @realDonaldTrump @realDonaldJNews @joerogan @joeroganhq $crsp $vrtx It was amazing to hear @JDVance describing to @joerogan the first ever approved CRISPR Gene editing therapy - $VRTX & $CRSP CASGEVY which already successfully cured Sickle Cell disease. The CRISPR & Gene Editing revolution is only just beginning & the future looks bright $XBI https://t.co/GYccz1t8iR It was amazing to hear @JDVance describing to @joerogan the first ever approved CRISPR Gene editing therapy - $VRTX & $CRSP CASGEVY which already successfully cured Sickle Cell disease. The CRISPR & Gene Editing"
X Link 2024-10-31T22:30Z [---] followers, [---] engagements

"$CRSP $NTLA $BEAM $VERV $CRBU $PRME $MGX $EDIT $XBI Here is another excellent 📊which demonstrates the grim situation of the entire CRISPR & Gene Editing sector. The only company which is included in @Stifels Top [--] BioTech companies is @CRISPRTX. No sign of the rest. $CRSP $NTLA $BEAM $VERV $CRBU $PRME $MGX $EDIT $XBI https://t.co/gUbffIpzCk Here is another excellent 📊which demonstrates the grim situation of the entire CRISPR & Gene Editing sector. The only company which is included in @Stifels Top [--] BioTech companies is @CRISPRTX. No sign of the rest. $CRSP $NTLA $BEAM $VERV $CRBU $PRME"
X Link 2024-11-04T21:30Z [---] followers, [----] engagements

"$azn 1/🚨Heres a crazy story which IMO due to Trumps re-election didnt receive the attention it deserved. According to @FT @AstraZenecas top executive in China - Leon Wang has been detained by the Chinese authorities & two current executives are under investigation $XBI $AZN https://t.co/TJIrRdtRRE 1/🚨Heres a crazy story which IMO due to Trumps re-election didnt receive the attention it deserved. According to @FT @AstraZenecas top executive in China - Leon Wang has been detained by the Chinese authorities & two current executives are under investigation $XBI $AZN https://t.co/TJIrRdtRRE"
X Link 2024-11-12T21:00Z [---] followers, [--] engagements

"China $xbi $azn $fxi $mchi @FT 4/Today China drives 13% of all of $AZN revenue - with $5.9B in sales last year in China alone. $AZN has been investing heavily in China in order to help it double its annual revenue to $80B by [----] from $46B in [----] especially by promoting its oncology drugs. 43% of the worlds https://t.co/LvZvfjiEH7 @FT 4/Today China drives 13% of all of $AZN revenue - with $5.9B in sales last year in China alone. $AZN has been investing heavily in China in order to help it double its annual revenue to $80B by [----] from $46B in [----] especially by promoting its oncology drugs."
X Link 2024-11-12T21:02Z [---] followers, [--] engagements

"$vrtx $crsp $xbi 🚨WOW @TIME has chosen the first ever approved CRISPR Gene editing therapy - $VRTX & $CRSP CASGEVY as part of the magazines list of [---] best Inventions of [----] which recognizes a wide variety of new products software or services that are making a difference in the world. $XBI https://t.co/7vHboa4bcH 🚨WOW @TIME has chosen the first ever approved CRISPR Gene editing therapy - $VRTX & $CRSP CASGEVY as part of the magazines list of [---] best Inventions of [----] which recognizes a wide variety of new products software or services that are making a difference in the world. $XBI"
X Link 2024-11-13T17:28Z [---] followers, [---] engagements

"$xbi $ntla $crsp 1/🚨WOW @intelliatx presented new & promising data from its Phase [--] study of Nex-z / $NTLA-2001 - a CRISPR/Cas9 Gene Editing therapy for treating transthyretin (ATTR) amyloidosis indicating that NTLA-2001 has the potential to eliminate ATTR following a one-time infusion $XBI https://t.co/V8Bb3XZyO3 1/🚨WOW @intelliatx presented new & promising data from its Phase [--] study of Nex-z / $NTLA-2001 - a CRISPR/Cas9 Gene Editing therapy for treating transthyretin (ATTR) amyloidosis indicating that NTLA-2001 has the potential to eliminate ATTR following a one-time infusion $XBI"
X Link 2024-11-16T22:16Z [---] followers, [---] engagements

"$xbi $sana 1/🚨 $SANA has revealed its plans to deeply narrow its pipeline & focus only on Type [--] Diabetes (UP421 & SC451) & on B-cell mediated autoimmune diseases (SC291-GLEAM). It also intends to terminate its oncology SC291 ARDENT trail & SC379 for CNS diseases. Not good at all $XBI🧵👇 https://t.co/MALfwNIiZg 1/🚨 $SANA has revealed its plans to deeply narrow its pipeline & focus only on Type [--] Diabetes (UP421 & SC451) & on B-cell mediated autoimmune diseases (SC291-GLEAM). It also intends to terminate its oncology SC291 ARDENT trail & SC379 for CNS diseases. Not good at all $XBI🧵👇"
X Link 2024-11-28T17:09Z [---] followers, [---] engagements

"$xbi $axsm The $AXSM Report: This is another one of my favorite companies with a very big pipeline and a lot of potential. They have [--] commercial drugs with several others in late-stage development. Auvelity is commercial for MDD and sales are growing at over 100%. They are expanding the The $AXSM Report: This is another one of my favorite companies with a very big pipeline and a lot of potential. They have [--] commercial drugs with several others in late-stage development. Auvelity is commercial for MDD and sales are growing at over 100%. They are expanding the"
X Link 2024-11-29T22:00Z [---] followers, [---] engagements

"$xbi $rxrx $nvda 1/A fascinating article was published in @TheEconomist recent edition - The World Ahead [----] which perfectly described the ever-growing rule of artificial intelligence in the BioTech ecosystem & how AI is about to make Pharma & the drug development process much faster $XBI 🧵👇 https://t.co/hhyWkTQ5s1 1/A fascinating article was published in @TheEconomist recent edition - The World Ahead [----] which perfectly described the ever-growing rule of artificial intelligence in the BioTech ecosystem & how AI is about to make Pharma & the drug development process much faster $XBI 🧵👇"
X Link 2024-12-01T21:16Z [---] followers, [---] engagements

"$xbi $blue $crsp 1/🚨More bad news for the Gene Therapy field. Last Wednesday the FDA raised concerns about life-threatening cases of Cancer - including Leukaemia in patients that were treated with Bluebird bios Skysona - a gene therapy treatment for cerebral adrenoleukodystrophy (CALD). $XBI https://t.co/Mw4R1tOyDI 1/🚨More bad news for the Gene Therapy field. Last Wednesday the FDA raised concerns about life-threatening cases of Cancer - including Leukaemia in patients that were treated with Bluebird bios Skysona - a gene therapy treatment for cerebral adrenoleukodystrophy (CALD). $XBI"
X Link 2024-12-03T17:49Z [---] followers, [---] engagements

"$xbi $crsp $beam $ntla $verv 1/🚨@CRISPRTX presented new promising data from its Phase 1/2 clinical trial of CTX112 - $CRSP CD19 allogeneic CAR T-cell therapy for treating cancer patients with R/R follicular & marginal zone lymphoma. The FDA has recently granted CTX112 a RMAT designation $XBI #ASH24 #ASH2024 https://t.co/pL8qVeXxW3 1/🚨@CRISPRTX presented new promising data from its Phase 1/2 clinical trial of CTX112 - $CRSP CD19 allogeneic CAR T-cell therapy for treating cancer patients with R/R follicular & marginal zone lymphoma. The FDA has recently granted CTX112 a RMAT designation $XBI"
X Link 2024-12-10T21:25Z [---] followers, [---] engagements

"$xbi $beam https://t.co/P1nrs2wqss https://t.co/P1nrs2wqss"
X Link 2024-12-14T21:49Z [---] followers, [---] engagements

"$LLY $NVO $JNJ $ABBV $MRK $RHHBY $NVS $AZN $AMGN $PFE $NVDA $XBI This @atlasventures excellent 📊 shows just how bad is the current situation of the BioTech & Pharma sectors. If the top ten big Pharma companies - $LLY $NVO $JNJ $ABBV $MRK $RHHBY $NVS $AZN $AMGN & $PFE has a combined market cap equal to that of $NVDA - its bad $XBI https://t.co/gxLqVrrE86 This @atlasventures excellent 📊 shows just how bad is the current situation of the BioTech & Pharma sectors. If the top ten big Pharma companies - $LLY $NVO $JNJ $ABBV $MRK $RHHBY $NVS $AZN $AMGN & $PFE has a combined market cap equal to"
X Link 2024-12-17T13:48Z [---] followers, [---] engagements

"$nvda 📈 $NVDA I know a lot of them are showing NVDA as a head and shoulders. Can this be a way to chart as well Is the stock flagging and consolidating to hit the upper trend line this week and close the year off at all time highs with Indexes already sitting there Wait and watch. https://t.co/EPiVq1KOqo 📈 $NVDA I know a lot of them are showing NVDA as a head and shoulders. Can this be a way to chart as well Is the stock flagging and consolidating to hit the upper trend line this week and close the year off at all time highs with Indexes already sitting there Wait and watch."
X Link 2024-12-18T03:14Z [---] followers, [---] engagements

"$xbi $crsp https://t.co/dpsTG0uh6q https://t.co/dpsTG0uh6q"
X Link 2024-12-21T21:55Z [---] followers, [---] engagements

"$beam $xbi 1/Each year @NatureMedicine asks leading innovators & scientists to pick [--] trails which they think will have a significant impact on medicine in that year. $BEAM-101s BEACON trail was selected as part of the [----] list & @davidrliu was chosen to explain its importance. $XBI 🧵👇 https://t.co/FnqRUgiT68 1/Each year @NatureMedicine asks leading innovators & scientists to pick [--] trails which they think will have a significant impact on medicine in that year. $BEAM-101s BEACON trail was selected as part of the [----] list & @davidrliu was chosen to explain its importance. $XBI 🧵👇"
X Link 2025-01-06T21:06Z [---] followers, [---] engagements

"$xbi $prme $beam 1/@BeamTxs #JPM25 presentation has highlighted its strategic priorities & future milestones for [----]. I have prepared a🧵which elaborates about the companys prioritised & restructured pipeline the progress $BEAM has made in [----] & its current corporate status. $XBI #JPM2025 https://t.co/6U7E1xEAvH 1/@BeamTxs #JPM25 presentation has highlighted its strategic priorities & future milestones for [----]. I have prepared a🧵which elaborates about the companys prioritised & restructured pipeline the progress $BEAM has made in [----] & its current corporate status. $XBI #JPM2025"
X Link 2025-01-17T05:33Z [----] followers, [---] engagements

"$beam $xbi Excellent thread by @yaireinhorn reviewing $BEAM update at JPM *Long Excellent thread by @yaireinhorn reviewing $BEAM update at JPM *Long"
X Link 2025-01-17T05:35Z [----] followers, [---] engagements

"$Xbi $ntla 1/🚨WOW @intelliatx announced that the first patient has been dosed in its HAELO Phase [--] study of $NTLA-2002 for the treatment of hereditary angioedema (HAE). Intellia expects to complete enrollment in 2H of [----] & submit a biologics license application (BLA) in [----] thus https://t.co/PrfVQammTL 1/🚨WOW @intelliatx announced that the first patient has been dosed in its HAELO Phase [--] study of $NTLA-2002 for the treatment of hereditary angioedema (HAE). Intellia expects to complete enrollment in 2H of [----] & submit a biologics license application (BLA) in [----] thus"
X Link 2025-01-22T17:50Z [----] followers, [---] engagements

"$xbi $vrtx $crsp 1/🚨WOW @VertexPharma & @CRISPRTX announced reimbursement agreement of CASGEVY - $VRTX & $CRSP CRISPR Gene Editing for Sickle Cell disease with NHS England. It means that eligible British SCD patients now have full access to CASGEVY alongside beta thalassemia (TDT) patients $XBI https://t.co/WWrGnMtuQO 1/🚨WOW @VertexPharma & @CRISPRTX announced reimbursement agreement of CASGEVY - $VRTX & $CRSP CRISPR Gene Editing for Sickle Cell disease with NHS England. It means that eligible British SCD patients now have full access to CASGEVY alongside beta thalassemia (TDT) patients"
X Link 2025-01-31T22:27Z [----] followers, [---] engagements

"here is my Jedi Knights list to follow on X #FF @Biotech2k1 @yaireinhorn @AlexFinnX @NeelyTamminga @EricTopol @ripster47 @Pharmdca @Biotech_SD @ArthurBenta @Optiongirl @Liathetrader @Maximus_Holla @DisruptorStocks @eliant_capital @rhemrajani9 @BrandonVanZee @elonmusk @xDaily"
X Link 2025-03-21T18:39Z [----] followers, [---] engagements

"$crsp $verv $ntla $beam $pfe $prme $xbi 1/Here is @barronsonlines excellent article which thoroughly analyses the current Heart Attack & Cardiovascular therapeutic landscape & how the various Gene Editing companies - $CRSP @scribetx & of course $VERV are taking the lead in this important & lucrative field $XBI 🧵👇 https://t.co/54oHQ0AGb4 1/Here is @barronsonlines excellent article which thoroughly analyses the current Heart Attack & Cardiovascular therapeutic landscape & how the various Gene Editing companies - $CRSP @scribetx & of course $VERV are taking the lead in this important &"
X Link 2025-06-08T18:32Z [----] followers, [---] engagements

"@cb_doge sounds great"
X Link 2025-06-19T19:27Z [----] followers, [--] engagements

"$nvda $rxrx $xbi $msft $goog $aapl Especially on the exact same day that $NVDA has become the first publicly traded company in history to reach a [--] trillion dollar market value I feel the need to emphasize what a huge and important role $NVDA and its inspiring CEO Jensen Huang play in the BioTech sector. Not only https://t.co/bkl3cGxRkz Especially on the exact same day that $NVDA has become the first publicly traded company in history to reach a [--] trillion dollar market value I feel the need to emphasize what a huge and important role $NVDA and its inspiring CEO Jensen Huang play in the"
X Link 2025-07-09T19:42Z [----] followers, [---] engagements

"$xbi $nvo $lly $arwr $wve $alny $mrk $abbv $rhhby $pfe $sny $vktx GLP-1 obesity drugs - such as $NVO Ozempic & Wegovy and $LLY Zepbound & Mounjaro have long became a household name - making Obesity the fastest growing market in BioTech. This excellent 📊👇- by Stifels @TimOpler describes the current obesity RNAi therapeutic landscape $XBI https://t.co/ndbigmAYxX GLP-1 obesity drugs - such as $NVO Ozempic & Wegovy and $LLY Zepbound & Mounjaro have long became a household name - making Obesity the fastest growing market in BioTech. This excellent 📊👇- by Stifels @TimOpler describes the current"
X Link 2025-07-12T18:51Z [----] followers, [---] engagements

"$xbi $crsp I have started to look into the most clinical advanced CRISPR Gene Editing company and the only one who currently has an approved drug - @CRISPRTX. $CRSP Q2 financial report is already on my desk and as always - I promise to share with you anything interesting I may find. $XBI https://t.co/pWxUrrpEbi I have started to look into the most clinical advanced CRISPR Gene Editing company and the only one who currently has an approved drug - @CRISPRTX. $CRSP Q2 financial report is already on my desk and as always - I promise to share with you anything interesting I may find. $XBI"
X Link 2025-08-08T18:04Z [----] followers, [---] engagements

"$xbi $nvo $lly Heres an excellent Reuters piece about Obesity drugmaker Novo Nordisks recent announcement that it is cutting its [----] full-year sales & profit outlook amid different hurdles - all which are detailed in my 🧵👇. $NVO continues to lose ground to its arch nemesis - $LLY $XBI https://t.co/vheM0u4zsf Heres an excellent Reuters piece about Obesity drugmaker Novo Nordisks recent announcement that it is cutting its [----] full-year sales & profit outlook amid different hurdles - all which are detailed in my 🧵👇. $NVO continues to lose ground to its arch nemesis - $LLY $XBI"
X Link 2025-08-13T17:28Z [----] followers, [---] engagements

"$xbi $beam 1/🚨@BeamTx announced that the U.S. FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to $BEAM-101 - BEAMs investigational genetically modified cell therapy for the treatment of sickle cell disease (SCD). This is an important milestone $XBI 🧵👇 https://t.co/fFSERi2QIa 1/🚨@BeamTx announced that the U.S. FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to $BEAM-101 - BEAMs investigational genetically modified cell therapy for the treatment of sickle cell disease (SCD). This is an important milestone $XBI 🧵👇 https://t.co/fFSERi2QIa"
X Link 2025-08-14T19:23Z [----] followers, [--] engagements

"$azn $xbi @AstraZeneca 1/🚨WOW According to this excellent Economists article 🧵👇 it seems that the big Pharma company AstraZeneca - one of Europes and Englands last remaining BioTech and Pharma moguls is moving its business away from England $AZN leaving the UK is a huge negative milestone https://t.co/WSq8AFLa3y 1/🚨WOW According to this excellent Economists article 🧵👇 it seems that the big Pharma company AstraZeneca - one of Europes and Englands last remaining BioTech and Pharma moguls is moving its business away from England $AZN leaving the UK is a huge negative milestone"
X Link 2025-08-25T05:20Z [----] followers, [---] engagements

"$xbi $wve $beam 1/🚨WOW @WaveLifeSci announced positive data from the [---] mg & [---] mg dose cohorts of its ongoing Phase 1b/2a RestorAATion-2 study evaluating $WVE-006 as a potential treatment for alpha-1 antitrypsin deficiency (AATD) patients which suffer from lung and liver malfunctions. $XBI https://t.co/XMLE7kwqBa 1/🚨WOW @WaveLifeSci announced positive data from the [---] mg & [---] mg dose cohorts of its ongoing Phase 1b/2a RestorAATion-2 study evaluating $WVE-006 as a potential treatment for alpha-1 antitrypsin deficiency (AATD) patients which suffer from lung and liver malfunctions. $XBI"
X Link 2025-09-03T17:19Z [----] followers, [---] engagements

"$hims $lly $nvo $pfe $bmy $gsk $rhhby $xbi $mrk $smmt 1/This excellent @barronsonline article wonderfully narrates the solution that big Pharma companies - such as $LLY $NVO $PFE $BMY $GSK and $RHHBY have found in order to deal with President Trumps amid pressure to lower their current drug prices for the American consumer - https://t.co/otXynmsV1P 1/This excellent @barronsonline article wonderfully narrates the solution that big Pharma companies - such as $LLY $NVO $PFE $BMY $GSK and $RHHBY have found in order to deal with President Trumps amid pressure to lower their current drug prices for"
X Link 2025-09-07T20:33Z [----] followers, [---] engagements

"$xbi $abbv $regn $sny $nvo $jnj $lly $amgn 1/This excellent WSJ article explains just how big of a role big Pharma companies such as $ABBV $REGN $SNY $NVO $JNJ $LLY $AMGN and others play in the American advertising industry - with an emphasis on TV commercials. According to the WSJ - in [----] big Pharma companies https://t.co/wyoxAHgS0G 1/This excellent WSJ article explains just how big of a role big Pharma companies such as $ABBV $REGN $SNY $NVO $JNJ $LLY $AMGN and others play in the American advertising industry - with an emphasis on TV commercials. According to the WSJ - in [----] big Pharma"
X Link 2025-09-15T19:44Z [----] followers, [---] engagements

"$ABBV $REGN $SNY $NVO $JNJ $LLY $AMGN $xbi According to the WSJ 📊👇 in [----] big Pharma companies such as $ABBV $REGN $SNY $NVO $JNJ $LLY $AMGN have spent an unprecedented sum of [--] billion dollars () on advertising in the U.S. alone 🧵👇 The biggest advertised drug segments were chronic conditions like https://t.co/DgZoPR2IGa According to the WSJ 📊👇 in [----] big Pharma companies such as $ABBV $REGN $SNY $NVO $JNJ $LLY $AMGN have spent an unprecedented sum of [--] billion dollars () on advertising in the U.S. alone 🧵👇 The biggest advertised drug segments were chronic conditions like"
X Link 2025-09-20T19:40Z [----] followers, [---] engagements

"$PFE $AMGN $BMY $ABBV $NVS $MRK $JNJ 1/An excellent explanation to the raising share prices all across the board - in both Big Pharma companies such as $PFE $AMGN $BMY $ABBV $NVS $MRK $JNJ and most of the Biotech companies can be found in this short and fascinating article written by WSJs excellent Heard on https://t.co/B96VIR9oIG 1/An excellent explanation to the raising share prices all across the board - in both Big Pharma companies such as $PFE $AMGN $BMY $ABBV $NVS $MRK $JNJ and most of the Biotech companies can be found in this short and fascinating article written by WSJs excellent"
X Link 2025-10-03T21:10Z [----] followers, [---] engagements

"$nvo $lly $xby #obesity 1/After the success of $NVO & $LLY GLP-1 drugs - such as Wegovy obesity is now a modern day BioTech gold rush backed by an unprecedented capital inflow & new pipelines. According to @Stifel there are currently [---] programs for obesity either approved or in development🧵👇 $XBI https://t.co/5agFeGAiJh 1/After the success of $NVO & $LLY GLP-1 drugs - such as Wegovy obesity is now a modern day BioTech gold rush backed by an unprecedented capital inflow & new pipelines. According to @Stifel there are currently [---] programs for obesity either approved or in development🧵👇"
X Link 2024-09-28T13:59Z [----] followers, [---] engagements

"$xbi $beam $ntla $prme $crbu $edit $crsp #crispr 🚨WOW The Gene Therapy & Gene Editing field continues to rapidly lose favour with BIoTech investors to higher-reward sectors like Obesity and Cancer. In [----] entrepreneurs of Gene Therapies and Gene Editing products raised less than $1.4B across [--] venture rounds This https://t.co/FZoHs3QwRF 🚨WOW The Gene Therapy & Gene Editing field continues to rapidly lose favour with BIoTech investors to higher-reward sectors like Obesity and Cancer. In [----] entrepreneurs of Gene Therapies and Gene Editing products raised less than $1.4B across [--] venture"
X Link 2025-03-22T21:48Z [----] followers, [---] engagements

"$lly $nvo $Xbi 🚨🚨WOW Eli Lilly reaching one trillion dollars in market value - for the first time in Pharma history is not only a huge milestone for $LLY itself but for the entire BioTech and Pharma ecosystem During his recent and excellent conversation with Stripes co-founder John https://t.co/srS3YztSKQ 🚨🚨WOW Eli Lilly reaching one trillion dollars in market value - for the first time in Pharma history is not only a huge milestone for $LLY itself but for the entire BioTech and Pharma ecosystem During his recent and excellent conversation with Stripes co-founder John"
X Link 2025-11-21T19:46Z [----] followers, [---] engagements

"$JNJ $RHHBY $LLY $NVO $NVS $PFE $AZN $BMY $GILD $xbi biotech This excellent 📊 by Stifels @timopler shows an unprecedented [---] trillion dollars firepower at the hands of the [--] biggest Pharma companies - $JNJ $RHHBY $LLY $NVO $NVS $PFE $AZN $BMY $GILD and more. The fact that all of these big Pharma companies are now facing a https://t.co/fvN7YaNkpM This excellent 📊 by Stifels @timopler shows an unprecedented [---] trillion dollars firepower at the hands of the [--] biggest Pharma companies - $JNJ $RHHBY $LLY $NVO $NVS $PFE $AZN $BMY $GILD and more. The fact that all of these big Pharma companies"
X Link 2025-11-25T12:25Z [----] followers, [---] engagements

"$nvo $lly $mtsr $vktx 1/Especially after todays massive $NVO Alzheimers failure👇 this short and excellent FT article sheds more light about the most interesting and talked-about clinical readout in the Pharma and BioTech ecosystem - whether $NVO GLP-1 drugs could be given to patients as a https://t.co/Ykjc06H3ca 1/Especially after todays massive $NVO Alzheimers failure👇 this short and excellent FT article sheds more light about the most interesting and talked-about clinical readout in the Pharma and BioTech ecosystem - whether $NVO GLP-1 drugs could be given to patients as a"
X Link 2025-11-25T19:18Z [----] followers, [---] engagements

"$xbi $lly $nvo $JNJ $RHHBY $LLY $NVO $NVS $PFE $AZN $BMY $GILD $verv $edit $lctx $sana Here is an excellent answer for a question which Im asked a lot - could there be a viable business model for a one & done Gene Therapy treatment and for CRISPR companies such as $PRME $BEAM $NTLA $CRSP $CRBU $MGX $LCTX $SANA and more. During his excellent conversation https://t.co/jTmOkzYS0E Here is an excellent answer for a question which Im asked a lot - could there be a viable business model for a one & done Gene Therapy treatment and for CRISPR companies such as $PRME $BEAM $NTLA $CRSP $CRBU $MGX $LCTX"
X Link 2025-11-26T12:27Z [----] followers, [---] engagements

"$xbi $lly $nvo $JNJ $RHHBY $LLY $NVO $NVS $PFE $AZN $BMY $GILD $verv $edit $lctx $sana #biotech Since the beginning of the year the Chinese BioTech ecosystem has experienced an exponential growth 🧵👇. But now - according to this excellent Stifels 📊 it seems that the table is turning with a sharp decline in the Hang Seng BioTech index which created a 43% performance https://t.co/DjFHyJuWTL Since the beginning of the year the Chinese BioTech ecosystem has experienced an exponential growth 🧵👇. But now - according to this excellent Stifels 📊 it seems that the table is turning with a sharp"
X Link 2025-11-28T18:49Z [----] followers, [---] engagements

"$xbi $lly $beam $crsp $ntla $prme $qure $edit $crbu $nvo $JNJ $RHHBY $NVS $PFE $AZN $BMY $GILD $verv $mgx $lctx $sana #biotech 1/Here is an optimistic beacon of hope for Thanksgiving weekend. One of the most important media outlets in the world - the Washington Post - has chosen to dedicate its main Thanksgiving editorial piece to the huge promise and recent breakthroughs in the Gene Therapy and CRISPR https://t.co/nCH6Hntn2y 1/Here is an optimistic beacon of hope for Thanksgiving weekend. One of the most important media outlets in the world - the Washington Post - has chosen to dedicate its"
X Link 2025-11-30T12:40Z [----] followers, [---] engagements

"#Biotech #China $jnj $mrk $gsk $xbi $pfe $lly $nvo $gild 1/🚨This short and interesting article - by FTs wonderful China Tech correspondent - @EleanorOlcott and William Sandlund FTs Asia market correspondent tells the story of maybe the most important and fascinating development in the BioTech and Pharma global ecosystem over the https://t.co/mkKOKdWJqM 1/🚨This short and interesting article - by FTs wonderful China Tech correspondent - @EleanorOlcott and William Sandlund FTs Asia market correspondent tells the story of maybe the most important and fascinating development in the BioTech and"
X Link 2025-12-03T20:35Z [----] followers, [--] engagements

"#Biotech #China $jnj $mrk $gsk $xbi $pfe $lly $nvo $gild $ntla $crsp $prme $beam $abbv $bmy $rhhby The unprecedented financial and commercial growth of the Chinese BioTech and Pharma ecosystem is undisputed. But this excellent 📊- taken from FTs comprehensive piece on the subject 🧵👇 shows IMO a much more important development - the exponential scientific progress made https://t.co/FE7PUP6IjF The unprecedented financial and commercial growth of the Chinese BioTech and Pharma ecosystem is undisputed. But this excellent 📊- taken from FTs comprehensive piece on the subject 🧵👇 shows IMO a"
X Link 2025-12-05T12:31Z [----] followers, [--] engagements

"$xbi $beam 1/🚨WOW @BeamTx presented new promising data from its BEACON Phase 1/2 trial of ristoglogene autogetemcel (risto-cel) - formerly known as $BEAM-101 in patients with sickle cell disease (SCD) which demonstrated rapid and robust fetal hemoglobin HbF of more than 60% a 40% https://t.co/adWxxBScHH 1/🚨WOW @BeamTx presented new promising data from its BEACON Phase 1/2 trial of ristoglogene autogetemcel (risto-cel) - formerly known as $BEAM-101 in patients with sickle cell disease (SCD) which demonstrated rapid and robust fetal hemoglobin HbF of more than 60% a 40% https://t.co/adWxxBScHH"
X Link 2025-12-07T19:36Z [----] followers, [---] engagements

"$xbi $wve huge day for obesity $lly $nvo $nvtx 1/🚨WOW @WaveLifeSci has presented positive clinical data from its Phase [--] INLIGHT Trial of $WVE-007 (INHBE) for Obesity demonstrating that a single [---] mg dose of WVE-007 led to an improvement in body composition with fat loss similar to GLP-1 drugs - such as $NVO Semaglutide https://t.co/insZdgQMfF 1/🚨WOW @WaveLifeSci has presented positive clinical data from its Phase [--] INLIGHT Trial of $WVE-007 (INHBE) for Obesity demonstrating that a single [---] mg dose of WVE-007 led to an improvement in body composition with fat loss similar to GLP-1 drugs"
X Link 2025-12-08T21:57Z [----] followers, [---] engagements

"$xbi new biotech company $prme $beam $lly $nvo $edit $mgx $crbu $sana @zhangf 1/🚨WOW Feng Zhangs new delivery company Aera Theraputics 🧵👇has presented new and promising preclinical data of its leading program AERA-109 - a targeted In Vivo CAR-T therapy designed to treat multiple B cell-mediated autoimmune diseases which uses Areas proprietary and https://t.co/uWrrxfxxcl 1/🚨WOW Feng Zhangs new delivery company Aera Theraputics 🧵👇has presented new and promising preclinical data of its leading program AERA-109 - a targeted In Vivo CAR-T therapy designed to treat multiple B cell-mediated"
X Link 2025-12-09T21:13Z [----] followers, [---] engagements

"$xbi #Biotech $LLY $NVO $JNJ $ABBV $MRK $RHHBY $NVS $AZN $AMGN $PFE This excellent @nature 📊👇 provides another example of the importance and the huge innovative role which small and mid-cap (SMID) BioTech companies play in the BioTech and Pharma ecosystem and how vital they are for the growth of big Pharma companies such as $LLY $NVO $JNJ https://t.co/1k9WBAN3F7 This excellent @nature 📊👇 provides another example of the importance and the huge innovative role which small and mid-cap (SMID) BioTech companies play in the BioTech and Pharma ecosystem and how vital they are for the growth of"
X Link 2025-12-10T13:47Z [----] followers, [---] engagements

"#biotech #crispr $beam $crsp $verv $ntla $edit $crbu 🚨 $BEAM Just announced that following the completion of Orbital Therapeutics acquisition by $BMY 🧵👇 - the company has received $255.1M in cash from Bristol-Myers Squibb on account of the [--] million Orbital shares held by @BeamTx which represents a 17% ownership stake in https://t.co/PYh3YFTLvb 🚨 $BEAM Just announced that following the completion of Orbital Therapeutics acquisition by $BMY 🧵👇 - the company has received $255.1M in cash from Bristol-Myers Squibb on account of the [--] million Orbital shares held by @BeamTx which represents"
X Link 2025-12-11T22:04Z [----] followers, [---] engagements

"#Biotech #China $jnj $mrk $gsk $xbi $pfe $lly $nvo $gild $ntla $crsp $prme $beam $abbv $bmy $rhhby Here is another short and excellent segment (0:47) from Eli Lillys CEO Dave Ricks - one of the top CEOs in the Pharma and BioTech ecosystem in-depth conversation with Stripes co-founder John collision in the Cheeky Pint podcast in which Dave wonderfully describes the https://t.co/gWopJOIvP4 Here is another short and excellent segment (0:47) from Eli Lillys CEO Dave Ricks - one of the top CEOs in the Pharma and BioTech ecosystem in-depth conversation with Stripes co-founder John collision in the"
X Link 2025-12-13T13:16Z [----] followers, [---] engagements

"$xbi $beam $prme One of the most important scientific breakthroughs of [----] was the personalised and custom-made genetic base editing treatment that was used to cure a new born baby named KJ which suffered from an incurable genetic disease known as CPS1 deficiency. 🧵👇This historical moment was https://t.co/68ELQDYsvG One of the most important scientific breakthroughs of [----] was the personalised and custom-made genetic base editing treatment that was used to cure a new born baby named KJ which suffered from an incurable genetic disease known as CPS1 deficiency. 🧵👇This historical moment"
X Link 2025-12-16T20:31Z [----] followers, [---] engagements

"$xbi $lly $nvo @MichaelAArouet For those interested in reading more - here is an excellent @nytimes piece about the rise & fall of Novo Nordisk - from a huge success story with its first GLP-1 blockbuster drug - Ozempic leading the Obesity market with 13M prescriptions in the U.S into losing it all to its @MichaelAArouet For those interested in reading more - here is an excellent @nytimes piece about the rise & fall of Novo Nordisk - from a huge success story with its first GLP-1 blockbuster drug - Ozempic leading the Obesity market with 13M prescriptions in the U.S into losing it all to its"
X Link 2025-12-17T16:16Z [----] followers, [---] engagements

"$prme $beam IMO the most important scientific event this week was the publication of @davidrlius new Nature article 🧵👇in which he presented a new and promising Gene Editing modality named PERT - Prime Editing-mediated Readthrough of premature termination codons. This new modality - which https://t.co/c8wCfP4cr1 IMO the most important scientific event this week was the publication of @davidrlius new Nature article 🧵👇in which he presented a new and promising Gene Editing modality named PERT - Prime Editing-mediated Readthrough of premature termination codons. This new modality - which"
X Link 2025-12-17T16:17Z [----] followers, [---] engagements

"$xbi $lly $nvo $amgn $biib $azn $nvs $abbv $gild $pfe $mrk $rhhby #biotech #China 🚨Another important and crucial aspect of the BioTech ecosystems massive transformation - from a generic-manufacturing industry into a cutting-edge and innovative BioTech hub is the exponential growth in the number of Chinese clinical assets being bought by the big Pharma https://t.co/o6Y6tzj3fq 🚨Another important and crucial aspect of the BioTech ecosystems massive transformation - from a generic-manufacturing industry into a cutting-edge and innovative BioTech hub is the exponential growth in the number of"
X Link 2025-12-21T16:52Z [----] followers, [---] engagements

"#biotech #crispr $crsp $lly $xbi Nice IMO the most interesting part in $CRSP recent update regarding zugo-cel 🧵👇 - @CRISPRTX proprietary allogeneic CAR T Cell Therapy targeting CD19 was its announcement regarding a new collaboration agreement signed with $LLY to evaluate zugo-cel together with Eli Lillys https://t.co/7iXUFhoIYr IMO the most interesting part in $CRSP recent update regarding zugo-cel 🧵👇 - @CRISPRTX proprietary allogeneic CAR T Cell Therapy targeting CD19 was its announcement regarding a new collaboration agreement signed with $LLY to evaluate zugo-cel together with Eli"
X Link 2025-12-24T13:27Z [----] followers, [---] engagements

"#biotech $xbi $lly $abvx $nvo $PFE $JNJ $NVS $BMY $ABBV $MRK $SNY Another testimony of $LLY increasing dominance in the BioTech and Pharma sector - especially amid a possible $ABVX mega M&A deal - can be seen in this excellent @evaluatepharma 📊👇. While the patent cliff scenario is expected to affect most of the Big Pharma companies - $PFE https://t.co/Va1I3m7jgZ Another testimony of $LLY increasing dominance in the BioTech and Pharma sector - especially amid a possible $ABVX mega M&A deal - can be seen in this excellent @evaluatepharma 📊👇. While the patent cliff scenario is expected to"
X Link 2025-12-26T12:45Z [----] followers, [---] engagements

"$xbi #biotech $crsp $ntla $beam $abvx $lly $nvo $crbu $edit $verv $mgx $edit $xbi $nvs 🚨WOW This excellent BofA 📊👇- describing [----] years of human technological innovation demonstrates once again the importance of CRISPR and Gene Editing after being chosen as part of the [--] most important inventions in human history - alongside AI the invention of print https://t.co/maIS2TTJnl 🚨WOW This excellent BofA 📊👇- describing [----] years of human technological innovation demonstrates once again the importance of CRISPR and Gene Editing after being chosen as part of the [--] most important inventions"
X Link 2025-12-29T13:31Z [----] followers, [---] engagements

"#biotech $xbi $MRK $JNJ $BMY $NVS $PFE $RHHBY This excellent 📊👇 by @evaluatepharma wonderfully shows just how big of an impact the patent cliff scenario is expected to have on big Pharma companies such as $MRK $JNJ $BMY $NVS $PFE and $RHHBY. As of today more than [---] separate drugs are due to face patent expiry and https://t.co/E7WefSfmlh This excellent 📊👇 by @evaluatepharma wonderfully shows just how big of an impact the patent cliff scenario is expected to have on big Pharma companies such as $MRK $JNJ $BMY $NVS $PFE and $RHHBY. As of today more than [---] separate drugs are due to face"
X Link 2026-01-02T19:59Z [----] followers, [--] engagements

"#biotech #pharma $xbi $abvx $gild $PFE $JNJ $NVS $BMY $ABBV $LLY $NVO $MRK $SNY Another important and crucial effect that the patent cliff scenario 🧵👇might have on big Pharma companies - such as $PFE $JNJ $NVS $BMY $ABBV $LLY $NVO $MRK $SNY and others - besides of course the loss of potential revenues is slow future growth over the next decade. This https://t.co/WSUiyGTU7K Another important and crucial effect that the patent cliff scenario 🧵👇might have on big Pharma companies - such as $PFE $JNJ $NVS $BMY $ABBV $LLY $NVO $MRK $SNY and others - besides of course the loss of potential"
X Link 2026-01-06T12:50Z [----] followers, [---] engagements

"@yaireinhorn @PM_ViktorOrban you are right yair Hungary is absolutely gorgeous and safe"
X Link 2026-01-07T11:19Z [----] followers, [---] engagements

"#biotech $xbi $azn $mrk $lly $nvo $xbi 1/🚨Here is another great article - by FT excellent global Pharma correspondent @aanuadeoye which wonderfully describes the rapid decline of the European and British Biotech and Pharma ecosystem and the growing gap between them and the American one. One important piece https://t.co/RXSnvQzbKj 1/🚨Here is another great article - by FT excellent global Pharma correspondent @aanuadeoye which wonderfully describes the rapid decline of the European and British Biotech and Pharma ecosystem and the growing gap between them and the American one. One important"
X Link 2026-01-07T13:45Z [----] followers, [--] engagements

"#biotechnology #biotech #hope $beam $verv @ScottGottliebMD Here is an excellent conversation of Dr. @ScottGottliebMD - the former FDA commissioner with @SquawkCNBCs @BeckyQuick in which Dr. Gottlieb discuss the ongoingclinical research & the regulatory efforts made by the FDA in order to find cures for more than [-----] different rare https://t.co/WBPH4vxwMu Here is an excellent conversation of Dr. @ScottGottliebMD - the former FDA commissioner with @SquawkCNBCs @BeckyQuick in which Dr. Gottlieb discuss the ongoingclinical research & the regulatory efforts made by the FDA in order to find cures"
X Link 2026-01-08T19:54Z [----] followers, [--] engagements

"@yaireinhorn thank you Yair for the wonderful threads and i really love your ✍🏿"
X Link 2026-01-15T12:53Z [----] followers, [---] engagements

"#biotech $prme $beam $crsp $ntla $sana $xbi So far I have finished writing two comprehensive 🧵which covered both $BEAM & $PRME #JPM26s presentations. $XBI Before I continue to write additional #JPM2026🧵s Im interested in hearing your thoughts about which company - if at all - would you want me to write about next So far I have finished writing two comprehensive 🧵which covered both $BEAM & $PRME #JPM26s presentations. $XBI Before I continue to write additional #JPM2026🧵s Im interested in hearing your thoughts about which company - if at all - would you want me to write about next"
X Link 2026-01-15T12:53Z [----] followers, [---] engagements

"#biotech $xbi #beam $beam $prme $xbi $sana $ntla $crbu #jpm26 #jpm2026 $lly $bmy $nvo https://t.co/pwboj13PmA https://t.co/pwboj13PmA"
X Link 2026-01-18T16:52Z [----] followers, [---] engagements

"#biotech $xbi $beam $prme $ntla $abvx $nvo $lly $sana $prat As you probably know I really like to prepare in-depth analysis of companies ER clinical readouts BioTech & Pharma latest news etc. Since its important for me to improve and to be the best that I can - I would appreciate if you could take a second and answer this survey👇🙏 As you probably know I really like to prepare in-depth analysis of companies ER clinical readouts BioTech & Pharma latest news etc. Since its important for me to improve and to be the best that I can - I would appreciate if you could take a second and answer this"
X Link 2026-01-20T20:34Z [----] followers, [---] engagements

"@yaireinhorn @ARKInvest @CathieDWood @Maximus_Holla @skathire @intelliatx @cremieuxrecueil @SamFazeli8 @bradloncar @BrandonVanZee thank yair but isnt [--] million dollars for a treatment is too high who could afford that"
X Link 2026-01-23T16:03Z [----] followers, [---] engagements

"@elonmusk I use only @grok and so [--] percent of ❤"
X Link 2026-01-26T18:23Z [----] followers, [--] engagements

"#biotecn $xbi $rvmd $mrk #biotechnology $abbv So the Merck - Revolution plot thickens. According to this exclusive report by WSJs @laurenthomas & @jonathanrockoff $MRK - which recently held talks to acquire $RVMD in a deal valued at $30B has announced that it is longer in discussions with Revolution Medicines https://t.co/veerdhSoI7 So the Merck - Revolution plot thickens. According to this exclusive report by WSJs @laurenthomas & @jonathanrockoff $MRK - which recently held talks to acquire $RVMD in a deal valued at $30B has announced that it is longer in discussions with Revolution Medicines"
X Link 2026-01-26T18:26Z [----] followers, [---] engagements

"$lctx $xbi $rhhby #Biotech 1/🚨WOW @lineagecell has announced that it has achieved the first milestone under its $RHHBY-Genentech collaboration agreement related to manufacturing and clinical development of OpRegen - $LCTX ocular Cell Therapy program 🧵👇. This event triggered a $5M milestone payment from https://t.co/K67LUaRG09 1/🚨WOW @lineagecell has announced that it has achieved the first milestone under its $RHHBY-Genentech collaboration agreement related to manufacturing and clinical development of OpRegen - $LCTX ocular Cell Therapy program 🧵👇. This event triggered a $5M milestone"
X Link 2025-11-27T13:54Z [----] followers, [---] engagements

"$crbu $prme $sana $beam $ntla $xbi 1/@CaribouBio announced that it will host an expert physician panel which will focus on how vispa-cel Caribous allogeneic anti-CD19 CAR-T cell therapy🧵👇 has the potential to expand patient access by enabling readily available CAR-T cell therapy care within sophisticated https://t.co/yzhrI5UZRY 1/@CaribouBio announced that it will host an expert physician panel which will focus on how vispa-cel Caribous allogeneic anti-CD19 CAR-T cell therapy🧵👇 has the potential to expand patient access by enabling readily available CAR-T cell therapy care within"
X Link 2025-12-02T15:37Z [----] followers, [---] engagements

"I admit that I have zero understanding in biotechnology. that is why I want to thank @yaireinhorn for making this article about $prme which made me understand what is going on and what all the hype is about https://t.co/5QFeB5nkNL https://t.co/5QFeB5nkNL"
X Link 2026-01-22T13:41Z [----] followers, [---] engagements

"@yaireinhorn @PrimeMedicine @davidrliu @zhaoweiasu thank you Yair for posting this but as someone who is clueless I want to ask you why do you think that pert is so important for $prme thanks again"
X Link 2026-01-25T16:34Z [----] followers, [---] engagements

"huge 🚨🚨🚨🚨 $ntla $crsp $prme $crbu $beam $verv #biotech #crispr #geneediting $xbi $lly $abvx $rvmd $nvo 🚨🚨WOW $NTLA has announced that the FDA has removed the clinical hold placed on the Investigational New Drug application (IND) for its MAGNITUDE-2 Phase [--] clinical trial of nex-z 🧵👇 for patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN). A https://t.co/XNsxrJ0NiG 🚨🚨WOW $NTLA has announced that the FDA has removed the clinical hold placed on the Investigational New Drug application (IND) for its MAGNITUDE-2 Phase [--] clinical trial of nex-z 🧵👇 for"
X Link 2026-01-27T13:49Z [----] followers, [---] engagements

"@bluesky you will never be x"
X Link 2026-01-29T22:40Z [----] followers, [--] engagements

"$ntla #crispr #Biotech #Biotechnology #geneediting $prme $beam $edit $crbu $xbi $abvx $rvmd $lly $nvo $azn $pfe $abbv $mrk $rhhby $sny $bmy $regn 1/In this great piece - WSJs excellent columnist @david_wainer is shedding light on a very interesting and somewhat predicted outcome of President Trumps Most Favoured Nation (MFN) new drug prices policy - which is trying to resolve a structural anomaly in the BioTech and https://t.co/TCyS7G2zts 1/In this great piece - WSJs excellent columnist @david_wainer is shedding light on a very interesting and somewhat predicted outcome of President Trumps"
X Link 2026-01-30T12:57Z [----] followers, [---] engagements

"$ntla #crispr #Biotech #Biotechnology #geneediting $prme $beam $edit $crbu $xbi $abvx $rvmd $lly $nvo $azn $pfe $abbv $mrk $rhhby $sny $bmy $regn Here is Eli Lillys $LLY CEO Dave Ricks - one of the top-notch CEOs in the Pharma and BioTech ecosystem explaining how the massive R&D investments needed in order to develop new drugs are practically being paid by American consumers which are subsidising the rest of the https://t.co/mOaeVqWFSf Here is Eli Lillys $LLY CEO Dave Ricks - one of the top-notch CEOs in the Pharma and BioTech ecosystem explaining how the massive R&D investments needed in"
X Link 2026-01-30T20:56Z [----] followers, [---] engagements

"@yaireinhorn @BillAckman the terminator [--] only this time Arnold isnt coming to save us"
X Link 2026-01-31T15:49Z [----] followers, [--] engagements

"$ntla #crispr #Biotech #Biotechnology #geneediting $prme $beam $edit $crbu $xbi $abvx $rvmd $lly $nvo $azn $pfe $abbv $mrk $rhhby $sny $bmy $regn Heres a 🧵with my #JPM26 presentation summaries of the different public CRISPR companies - $BEAM $PRME & $CRSP 👇. Each summary - although based on the companys own presentation is my own subjective impression & is by no means a financial advice. Please do your own DD 🙏 $XBI https://t.co/nOzBB7F5kO Heres a 🧵with my #JPM26 presentation summaries of the different public CRISPR companies - $BEAM $PRME & $CRSP 👇. Each summary - although based on the"
X Link 2026-02-01T18:25Z [----] followers, [---] engagements

"$ntla #crispr #Biotech #genetherapy #Cancer @FightBlindness $prme $beam $edit $crbu $xbi $abvx $rvmd $lly $nvo $azn $pfe $abbv $mrk $rhhby $sny $bmy $regn $wve $arwr $btc 1/In one of the best articles that Ive read recently - Washington Posts excellent science reporter @Carolynyjohnson sheds light on a less known aspect of the Gene Therapy and CRISPR Gene Editing field. Although many Gene Therapies and CRISPR Gene Editing therapies are https://t.co/4e2uLzrpx6 1/In one of the best articles that Ive read recently - Washington Posts excellent science reporter @Carolynyjohnson sheds light on a"
X Link 2026-02-02T12:42Z [----] followers, [---] engagements

"this is crazy $lly is investing more than in #biotech research and development $crispr $nvo $crsp $ntla $verv $edit $crsp $sana $mrk $nvs $rhhby $jnj $pfe $xbi $amgn $azn $mrna #mrna While many are amazed by Eli Lillys fantastic success and by its superiority over $NVO not many are aware to the fact that according to Eli Lillys CEO Dave Ricks - $LLY has invested $14B () in BioTech R&D this year which is more than what Germany has invested 🧵👇 $XBI https://t.co/96iOJ6DAFi While many are amazed by Eli Lillys fantastic success and by its superiority over $NVO not many are aware to the fact that"
X Link 2026-02-05T14:38Z [----] followers, [---] engagements

"$PFE $JNJ $NVS $BMY $ABBV $MRK $SNY #biotech #pharma #cancer $nvo $lly $xbi $amgn $rhhby $aapl $tsla @xai @SpaceX Another testimony of Eli Lillys far-sighted strategy and how it helps $LLY to strengthen its dominance in the BioTech and Pharma sector can be seen in this excellent @evaluatepharma 📊👇. While the patent cliff scenario is expected to affect most of the Big Pharma companies - https://t.co/1tCksqwpWR Another testimony of Eli Lillys far-sighted strategy and how it helps $LLY to strengthen its dominance in the BioTech and Pharma sector can be seen in this excellent @evaluatepharma"
X Link 2026-02-06T21:40Z [----] followers, [---] engagements

"$hims is toast and Ill bet that the guys from $nvo and $lly are drinking champagne I never really understood how $HIMS was allowed in the first place to practically built its entire business model by relying on other BioTech and Pharma companies IP - mainly $NVO & $LLY proprietary obesity drugs. That is why this statement by @HHSGCMikeStuart - that he referred https://t.co/1JeS03ZMxf I never really understood how $HIMS was allowed in the first place to practically built its entire business model by relying on other BioTech and Pharma companies IP - mainly $NVO & $LLY proprietary obesity"
X Link 2026-02-07T12:26Z [----] followers, [---] engagements

"$xbi $rxrx $exai #ai $nvda https://t.co/U7NQMNFq7s https://t.co/U7NQMNFq7s"
X Link 2024-12-07T21:08Z [----] followers, [---] engagements

"RT @yaireinhorn: Here is my favourite weekly 🧵- made by my dear friend @BiopharmIQ - which is a comprehensive recap of the past week in Bio"
X Link 2026-02-08T18:10Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing